{"title":"Acute Angioedema in a Patient on Long-term Angiotensin Converting Enzyme Inhibitor Following Oral Surgery: A Case Report","authors":"C. Awoniyi, Steven Yannaras, Julia M. Bauerfeind","doi":"10.2174/1874321801307010049","DOIUrl":null,"url":null,"abstract":"A relatively common side effect of angiotensin converting enzyme inhibitors (ACE-I), used for the treatment of high blood pressure, is angioedema. Whereas, angioedema due to ACE-I usually appear during the first few days or weeks of treatment, delayed onset, years after initiation of treatment is often unrecognized and can lead to life-threatening adverse events. We present a case report of rapidly progressive tongue swelling a few hours following oral surgery in a 62-year-old male who had been on ACE-I therapy for seven years. Prompt recognition and treatment prevented an impending respiratory compromise that could have been catastrophic.","PeriodicalId":272376,"journal":{"name":"The Open Anesthesiology Journal","volume":"51 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Anesthesiology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874321801307010049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A relatively common side effect of angiotensin converting enzyme inhibitors (ACE-I), used for the treatment of high blood pressure, is angioedema. Whereas, angioedema due to ACE-I usually appear during the first few days or weeks of treatment, delayed onset, years after initiation of treatment is often unrecognized and can lead to life-threatening adverse events. We present a case report of rapidly progressive tongue swelling a few hours following oral surgery in a 62-year-old male who had been on ACE-I therapy for seven years. Prompt recognition and treatment prevented an impending respiratory compromise that could have been catastrophic.